Search Results
Found 1 results
510(k) Data Aggregation
(101 days)
QMS TOBRAMYCIN
The QMS® Tobramycin assay is intended for the quantitative determination of tobramycin in human serum or plasma on automated clinical chemistry analyzers.
The results obtained are used in the diagnosis and treatment of tobramycin overdose and in monitoring levels of tobramycin to help ensure appropriate therapy.
The QMS® Tobramycin assay system is a homogeneous assay utilizing particle agglutination technology and is based on the competitive binding principle. The assay consists of reagents R1: anti- tobramycin monoclonal antibody and R2: tobramycin -coated microparticles. A six-level set of QMS® Tobramycin Calibrators (A through F) is used to calibrate the assay.
Here's a breakdown of the acceptance criteria and study information for the Seradyn QMS® Tobramycin assay, based on the provided 510(k) summary:
Acceptance Criteria and Device Performance
Test | Acceptance Criteria | Reported Device Performance |
---|---|---|
Accuracy | % Recovery: 100 ± 10% | Mean Percent Recovery: 94.14% |
Linearity | % Recovery: 100 ± 10% | Correlation coefficient (R²): 0.9996 |
Precision | Total CV: |
Ask a specific question about this device
Page 1 of 1